Skip to main content
Signal8

Swanton Robert Charles

SEC insider (Form 3/4/5 filer). CIK 0002079922. Director at BICYCLE THERAPEUTICS PLC (BCYC). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in CAMBRIDGE.

Companies Swanton Robert Charles has filed insider reports for

  • BICYCLE THERAPEUTICS PLC (BCYC): Director
Swanton Robert Charles profile photo

Swanton Robert Charles

CIK: 0002079922

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BICYCLE THERAPEUTICS PLC logo
BCYC

BICYCLE THERAPEUTICS PLC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 2, 2026
    Sale
    Direct
    3.4K shares at avg. $3.47$12K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 2, 2026
    Award
    Direct
    3.7K shares-
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 2, 2025
    Sale
    Direct
    102 shares at avg. $8.55$872.1
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Aug 12, 2025
    Award
    Direct
    12.5K shares-

1-4 of 4